Russia announces approval of CoviVac, a third vaccine for domestic use

Full article
Russia has already approved two Covid-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute
Russia approved a third coronavirus vaccine for domestic use, Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot, labeled CoviVac and produced by the Chumakov Centre, have yet to begin.
Russia has already approved two Covid-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results.
The pre-emptive approvals had raised concerns among some scientists in the West, but inoculations with those first two shots began on a mass scale in Russia only after trials were concluded and showed success.

Related Keywords

South Africa ,Novosibirsk ,Novosibirskaya Oblast ,Russia ,United Kingdom ,Petersburg ,Sankt Peterburg ,Russians ,Russian ,Alexander Chepurnov ,Tatiana Golikova ,Aidar Ishmukhametov ,Albert Sabin ,Mikhail Mishustin ,Mikhail Murashko ,Mikhail Chumakov ,Moscow Gamaleya Institute Russia ,Chumakov Centre ,Moscow Gamaleya Institute ,Vector Institute ,Gamaleya Institute ,Prime Minister Mikhail Mishustin ,Health Minister Mikhail Murashko ,Prime Minister Mishustin ,Cold War ,Vladimir Putin ,Deputy Prime Minister Tatiana Golikova , ,ரஷ்யா ,ஒன்றுபட்டது கிஂக்டம் ,பீட்டர்ஸ்பர்க் ,ரஷ்யர்கள் ,ரஷ்ய ,ஆல்பர்ட் சபின் ,திசையன் நிறுவனம் ,குளிர் போர் ,விளாடிமிர் புட்டின் ,